[用于预防和治疗出血的局部注射松酸]
Jeppe Hjembæk-Brandt1,2, Mathias Maagaard3, Christine Nygaard Svendsen2
1Afdeling for Plastikkirurgi, Københavns Universitetshospital - Herlev Hospital.
Ugeskrift for laeger
|June 23, 2025
概括
特兰胺酸 (TXA) 有效地减少了30%-40%的出血. 局部TXA的使用显示出与全身疗法相似的疗效,副作用较少,这使其成为抗纤维素解药疗法的更安全替代品.
科学领域:
- 药理学和治疗学 药理学和治疗学
- 医学研究 医学研究
背景情况:
- 特兰胺酸 (TXA) 是世卫组织基本药物名单上列出的重要抗纤维解药物.
- 系统性TXA的管理被广泛用于其已被证明的有效性,在各种临床环境中减少血液损失.
- 对与全身TXA相关的血栓栓塞风险的担忧引发了对替代药物管理方法的兴趣.
研究的目的:
- 审查局部特兰胺酸 (TXA) 的疗效和安全性.
- 为了比较本地TXA与传统系统管理的结果.
- 评估局部TXA在减轻血栓栓塞事件风险方面的潜力.
主要方法:
- 对调查局部TXA管理的研究进行了全面的文献审查.
- 对TXA局部应用的临床场景的分析.
- 对局部TXA使用报告的疗效和不良事件数据的评估.
主要成果:
- 局部给药的TXA显示出显著的抗纤维解质作用,与全身给药相当.
- 研究表明,局部TXA应用可以大约减少30%-40%的出血.
- 在经过审查的研究中,在局部TXA给药时观察到最小的系统性副作用.
结论:
- 局部注射的三胺酸 (TXA) 是一种可行的,有效的替代系统使用.
- 这种方法提供了可比的静血效益,降低了风险概况.
- 局部TXA为抗纤维解药疗法提供了一个有前途的策略,提高了患者的安全性.
相关概念视频
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Anticoagulant Drugs: Low-Molecular-Weight Heparins
924
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
924
Venous Thrombosis IV: Nursing Management
27
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
27
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Esophageal Varices-II: Clinical Features and Management
149
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
149
Introduction to Hemostasis
9.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.0K


